Chen Yi-Ren, Fredrick Douglas, Steinberg Gary K, Liao Yaping J
Department of Neurosurgery, Stanford University Medical Center.
Ophthalmology, Stanford University Medical Center.
Cureus. 2016 Apr 1;8(4):e553. doi: 10.7759/cureus.553.
We report a long-term eye movement study of a 68-year-old female with pontomedullary junction cavernous malformation whose dysconjugate nystagmus was treated with retrobulbar botulinum toxin A injections. Sequential, bilateral retrobulbar injections of botulinum toxin A were performed. Injections immediately decreased oscillopsia and nystagmus, and improved visual acuities. One to three months following injection, three-dimensional infrared oculography measured a significant 39-100% (P = 0.001) decrease in nystagmus amplitudes at multiple dimensions. This improvement diminished by six months in the right eye but sustained for about one year in the left eye. Over two years, botulinum toxin A injections were performed twice in the left eye and five times in the right eye. Our study supported the safe and effective use of repetitive retrobulbar botulinum toxin A injections in symptomatic nystagmus that failed medical therapy.
我们报告了一项针对一名68岁患有脑桥延髓交界海绵状畸形的女性的长期眼动研究,其眼球运动失调性眼球震颤通过球后注射肉毒杆菌毒素A进行治疗。进行了双侧球后肉毒杆菌毒素A的序贯注射。注射后立即减轻了视振荡和眼球震颤,并提高了视力。注射后1至3个月,三维红外眼动图测量发现,多个维度的眼球震颤幅度显著降低了39%-100%(P = 0.001)。这种改善在右眼6个月时减弱,但在左眼持续了约一年。在两年多的时间里,左眼进行了2次肉毒杆菌毒素A注射,右眼进行了5次。我们的研究支持在药物治疗无效的有症状眼球震颤中安全有效地重复进行球后肉毒杆菌毒素A注射。